Apr 1, 2022
Partnership With the Health Tech World
The company has entered an exciting partnership with the Health Tech World to introduce George and his vision for the future.
Health Tech World is an accessible but singularly specialist title, providing expert commentary on the critical and dynamic sector of HealthTech in the global economy. It is brought to be by Aspect Publishing, which also produces Neuro Rehab Times, the world’s leading magazine for brain and spine professionals. The content focuses on all aspects of new and future healthcare tech and is backed by a team of award-winning journalists, experts and analysts. The interest and main focus is the very latest breakthroughs, and pioneers who are revolutionising health and wellbeing around the world. Health Tech World is an essential source of information for all those with a professional interest in health technology and all of its supply chains. It supports collaboration, investment, research and, ultimately, commercialisation and the improved health outcomes it generates.
MediSieve's CEO, George Frodsham, shared a commentary thought piece on running a start-up and making decisions as a way to introduce MediSieve and himself. George talked about the hardships and uncertainties of making decisions. Leading a start-up requires quick and yet smart decision making on a daily basis. George stated that to avoid decision paralysis
"We need to accept that we can never truly know all of the consequences of our decisions. We need to be willing to take risks and to be able to take important decisions despite uncertainty."
His advice to aspiring entrepreneurs or those already in the business is to seek advice and ask for help:
"To have a chance of success, entrepreneurs need to get over the fear of being wrong and accept the fact that they will be heading into the unknown. We must all decide to decide."
George also discussed his rapid journey from waiting tables to becoming CEO of MediSieve with Rob Dale in episode 3 of the HT podcast. The discussion acknowledged that the road to success is not all sunshine and rainbows.
MediSieve is excited about this new partnerships and looks forward to participating in upcoming events, podcast episodes or sharing more thoughts and advice!
Full article can be found here:
The full podcast can be found here:
About Magnetic Blood Filtration
MediSieve's Magnetic Blood Filtration Platform is intended to enable the rapid and specific depletion of specific agents from the bloodstream of patients. The extracorporeal therapy uses therapeutic Magnetic Beads that are designed to bind specifically to the clinical target. The Beads are introduced into the extracorporeal circuit during the therapy, mixing with the patient’s blood and binding to the clinical targets. The Delivery Platform captures all the Magnetic Beads and bound targets, preventing their return to the patient.
MediSieve is a London-based BioTech start-up that has developed Magnetic Blood Filtration, a revolutionary platform therapy that enables the physical removal of specific substances from the bloodstream of patients. It can be used (1) as a direct treatment, (2) to increase the safety and efficacy of other therapies, or (3) to enable personalised medicine. The company is a spin-off from University College London and is developing its products at the White City Innovation District in West London. MediSieve is actively seeking investment and partnerships.
INVESTOR AND PARTNERSHIP CONTACT: